Cardlytics Inc (NASDAQ:CDLX) has a beta value of 1.33 and has seen 1.51 million shares traded in the recent trading session. The company, currently valued at $520.46M, closed the recent trade at $13.26 per share which meant it lost -$1.24 on the day or -8.55% during that session. The CDLX stock price is -47.59% off its 52-week high price of $19.57 and 80.62% above the 52-week low of $2.57. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.44 million shares traded. The 3-month trading volume is 1.07 million shares.
Cardlytics Inc (NASDAQ:CDLX) trade information
Sporting -8.55% in the red today, the stock has traded in the green over the last five days, when the CDLX stock price touched $13.26 or saw a rise of 10.1%. Year-to-date, Cardlytics Inc shares have moved 43.97%, while the 5-day performance has seen it change 56.18%. Over the past 30 days, the shares of Cardlytics Inc (NASDAQ:CDLX) have changed 95.86%. Short interest in the company has seen 4.36 million shares shorted with days to cover at 4.
Cardlytics Inc (CDLX) estimates and forecasts
The company’s shares have lost -30.76% over the past 6 months. Revenue growth from the last financial year stood is estimated to be 9.20%.
3 analysts offering their estimates for the company have set an average revenue estimate of $71.69 million for the current quarter. 3 have an estimated revenue figure of $81.39 million for the next quarter concluding in Jun 2024.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -5.75% over the past 5 years. Earnings growth for 2024 is a modest 65.04% while over the next 5 years, the company’s earnings are expected to increase by 44.10%.
CDLX Dividends
Cardlytics Inc is expected to release its next earnings report between May 02 and May 06 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Cardlytics Inc (NASDAQ:CDLX)’s Major holders
Insiders own 3.69% of the company shares, while shares held by institutions stand at 67.32% with a share float percentage of 69.90%. Investors are also buoyed by the number of investors in a company, with Cardlytics Inc having a total of 177 institutions that hold shares in the company. The top two institutional holders are CAS Investment Partners, LLC with over 5.42 million shares worth more than $34.23 million. As of Jun 29, 2023, CAS Investment Partners, LLC held 14.36% of shares outstanding.
The other major institutional holder is Blackrock Inc., with the holding of over 2.86 million shares as of Jun 29, 2023. The firm’s total holdings are worth over $18.05 million and represent 7.57% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard Total Stock Market Index Fund and iShares Russell 2000 ETF. As of Jun 29, 2023, the former fund manager holds about 2.64% shares in the company for having 1.0 million shares of worth $6.29 million while later fund manager owns 0.82 million shares of worth $13.62 million as of Aug 30, 2023, which makes it owner of about 2.17% of company’s outstanding stock.
